Back to mobile site

Sucampo Pharma (SCMP) Tops Q4 EPS by 24c

March 8, 2016 6:34 AM EST

Sucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.43, $0.24 better than the analyst estimate of $0.19. Revenue for the quarter came in at $55.4 million versus the consensus estimate of $42.72 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings